| Bioactivity | Antileishmanial agent-31 (Compound p1) is a pyrazole derivative. Antileishmanial agent-31 has anti-leishmania activity with an IC50 of 35.53 μg/mL. In addition, Antileishmanial agent-31 has high stability. Antileishmanial agent-31 can be used for anti-leishmaniasis research[1]. |
| CAS | 861382-34-5 |
| Formula | C11H11ClN2 |
| Molar Mass | 206.67 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sabet R, et al. Pyrazole derivatives as antileishmanial agents: Biological evaluation, molecular docking study, DFT analysis and ADME prediction. Heliyon. 2024 Nov 19;10(23):e40444. |
Antileishmanial agent-31
CAS: 861382-34-5 F: C11H11ClN2 W: 206.67
Antileishmanial agent-31 (Compound p1) is a pyrazole derivative. Antileishmanial agent-31 has anti-leishmania activity w
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.